Analysis of the mitochondrial 4977 bp deletion in patients with hepatocellular carcinoma

1Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology. 2004; 127(5 Suppl 1): S5–S16.BoschFXRibesJDiazMCleriesR. Primary liver cancer: Worldwide incidence and trends Gastroenterology. 2004 127 5 Suppl 1 S5S16Search in Google Scholar

2Frenette C, Gish R. Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications. World J Gastroenterol. 2012; 18(6): 498-506.FrenetteCGishR. Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications World J Gastroenterol. 2012 18 6 498 506Search in Google Scholar

3El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gas-troenterology. 2007; 132(7): 2557-2576.El-SeragHBRudolphKL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis Gas-troenterology 2007 132 7 2557 2576Search in Google Scholar

4Mitchell P, Moyle J. Chemiosmotic hypothesis of oxidative phosphorylation. Nature. 1967; 213(5072): 137-139.MitchellPMoyleJ. Chemiosmotic hypothesis of oxidative phosphorylation Nature. 1967 213 5072 137 139Search in Google Scholar

5Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene. 2006; 25(34): 4647-4662.BrandonMBaldiPWallaceDC. Mitochondrial mutations in cancer Oncogene. 2006 25 34 4647 4662Search in Google Scholar

6Chinnery PF, Samuels DC, Elson J, Turnbull DM. Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: Is there a common mechanism? Lancet. 2002; 360(9342): 1323-1325.ChinneryPFSamuelsDCElsonJTurnbullDM. Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: Is there a common mechanism? Lancet. 2002 360 9342 1323 1325Search in Google Scholar

7Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature. 1988; 331(6158): 717-719.HoltIJHardingAE Morgan-HughesJA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies Nature. 1988 331 6158 717 719Search in Google Scholar

8Ding Z, Ji J, Chen G, Fang H, Yan S, Shen L, et al. Analysis of mitochondrial DNA mutations in Dloop region in thyroid lesions. Biochim Biophys Acta. 2010; 1800(3): 271-274.DingZJiJChenGFangHYanSShenL Analysis of mitochondrial DNA mutations in Dloop region in thyroid lesions Biochim Biophys Acta. 2010 1800 3 271 274Search in Google Scholar

9Chen T, He J, Shen L, Fang H, Nie H, Jin T, et al. The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer. BMC Med Genet. 2011; 12: 8 (https://www.ncbi.nlm.nih.gov/pubmed/21232124).ChenTHeJShenLFangHNieHJinT The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer BMC Med Genet. 2011 12 8 https://www.ncbi.nlm.nih.gov/pubmed/21232124Search in Google Scholar

10Lee HC, Wei YH. Mitochondrial DNA instability and metabolic shift in human cancers. Int J Mol Sci. 2009; 10(2): 674-701.LeeHCWeiYH. Mitochondrial DNA instability and metabolic shift in human cancers Int J Mol Sci. 2009 10 2 674 701Search in Google Scholar

11Lu J, Sharma LK, Bai Y. Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res. 2009; 19(7): 802-815.LuJSharmaLKBaiY. Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis Cell Res. 2009 19 7 802 815Search in Google Scholar

12Kao S, Chao HT, Wei YH. Mitochondrial deoxyribonucleic acid 4977-bp deletion is associated with diminished fertility and motility of human sperm. Biol Reprod. 1995; 52(4): 729-736KaoSChaoHTWeiYH. Mitochondrial deoxyribonucleic acid 4977-bp deletion is associated with diminished fertility and motility of human sperm Biol Reprod. 1995 52 4 729 736Search in Google Scholar

13Lee HC, Hsu LS, Yin PH, Lee LM, Chi CW. Heteroplasmic mutation of mitochondrial DNA D-loop and 4977-bp deletion in human cancer cells during mitochondrial DNA depletion. Mitochondrion. 2007; 7(1-2): 157-163.LeeHCHsuLSYinPHLeeLMChiCW. Heteroplasmic mutation of mitochondrial DNA D-loop and 4977-bp deletion in human cancer cells during mitochondrial DNA depletion Mitochondrion. 2007 7 1-2 157 163Search in Google Scholar

14Wang E, Wong A, Cortopassi G. The rate of mitochondrial mutagenesis is faster in mice than humans. Mutat Res. 1997; 377(2): 157-166.WangEWongACortopassiG. The rate of mitochondrial mutagenesis is faster in mice than humans Mutat Res. 1997 377 2 157 166Search in Google Scholar

15Ye C, Shu XO, Wen W, Pierce L, Courtney R, Gao YT, et al. Quantitative analysis of mitochondrial DNA 4977-bp deletion in sporadic breast cancer and benign breast diseases. Breast Cancer Res Treat. 2008; 108(3): 427-434.YeCShuXOWenWPierceLCourtneyRGaoYT Quantitative analysis of mitochondrial DNA 4977-bp deletion in sporadic breast cancer and benign breast diseases Breast Cancer Res Treat. 2008 108 3 427 434Search in Google Scholar

16Tseng LM, Yin PH, Chi CW, Hsu CY, Wu CW, Lee LM, et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer. 2006; 45(7): 629-638.TsengLMYinPHChiCWHsuCYWuCWLeeLM Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer Genes Chromosomes Cancer. 2006 45 7 629 638Search in Google Scholar

17Macmillan CJ, Shoubridge EA. Mitochondrial DNA depletion: Prevalence in a pediatric population referred for neurologic evaluation. Pediatr Neurol. 1996; 14(3): 203-210.MacmillanCJShoubridgeEA. Mitochondrial DNA depletion: Prevalence in a pediatric population referred for neurologic evaluation Pediatr Neurol. 1996 14 3 203 210Search in Google Scholar

18Shen J, Wan J, Song R, Zhao H. Peripheral blood mitochondrial DNA copy number, length heteroplasmy, and breast cancer risk: A replication study. Carcinogenesis. 2015; 36(11): 1307-1313.ShenJWanJSongRZhaoH. Peripheral blood mitochondrial DNA copy number, length heteroplasmy, and breast cancer risk: A replication study Carcinogenesis. 2015 36 11 1307 1313Search in Google Scholar

19Mambo E, Chatterjee A, Xing M, Tallini G, Haugen BR, Yeung SC, et al. D. Tumor-specific changes in mtDNA content in human cancer. Int J Cancer. 2005; 116(6): 920-924.MamboEChatterjeeAXingMTalliniGHaugenBRYeungSC D. Tumor-specific changes in mtDNA content in human cancer Int J Cancer. 2005 116 6 920 924Search in Google Scholar

20Laderman KA, Penny JR, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G. Aging-dependent functional alterations of mitochondrial DNA (mtDNA) from human fibroblasts transferred into mtDNA-less cells. J Biol Chem. 1996; 271(27): 15891-15897.LadermanKAPennyJRMazzucchelliFBresolinNScarlatoGAttardiG. Aging-dependent functional alterations of mitochondrial DNA (mtDNA) from human fibroblasts transferred into mtDNA-less cells J Biol Chem. 1996 271 27 15891 15897Search in Google Scholar

21Agaronyan K, Morozov YI, Anikin M, Temiakov D. Mitochondrial biology. Replication-transcription switch in human mitochondria. Science. 2015; 347(6221): 548-551.AgaronyanKMorozovYIAnikinMTemiakovD. Mitochondrial biology. Replication-transcription switch in human mitochondria Science. 2015 347 6221 548 551Search in Google Scholar

22Copeland WC, Longley MJ. Mitochondrial genome maintenance in health and disease. DNA Repair (Amsterdam). 2014; 19: 190-198 (https://ncbi.nlm.nih.gov/pubmed/24780559).CopelandWCLongleyMJ. Mitochondrial genome maintenance in health and disease DNA Repair (Amsterdam). 2014 19 190198 https://ncbi.nlm.nih.gov/pubmed/24780559Search in Google Scholar

23Higgs MR, Chouteau P, Lerat H. ‘Liver let die:’ Oxidative DNA damage and hepatotropic viruses. J Gen Virol. 2014; 95(Pt 5): 991-1004.HiggsMRChouteauPLeratH. ‘Liver let die:’ Oxidative DNA damage and hepatotropic viruses J Gen Virol. 2014 95 5 9911004Search in Google Scholar

24Brown DI, Griendling KK. Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ Res. 2015; 116(3): 531-549.BrownDIGriendlingKK. Regulation of signal transduction by reactive oxygen species in the cardiovascular system Circ Res. 2015 116 3 531 549Search in Google Scholar

25Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010; 44(5): 479-496.LiouGYStorzP. Reactive oxygen species in cancer Free Radic Res. 2010 44 5 479 496Search in Google Scholar

26Fang FC. Antimicrobial actions of reactive oxygen species. MBio. 2011; 2(5): pii: e00141-e00111 (https://www.ncbi.nlm.nih.gov.pubmed/21896680).FangFC. Antimicrobial actions of reactive oxygen species MBio. 2011 2 5 e00141e00111 https://www.ncbi.nlm.nih.gov.pubmed/21896680Search in Google Scholar